US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

275.21

+24.809.90%

Volume:301.36K

Turnover:81.82M

Market Cap:543.40M

PE:- -

High:280.62

Open:265.00

Low:263.72

Close:250.41

52wk High:341.93

52wk Low:77.07

Shares:1.97M

Float Shares:1.97M

Volume Ratio:4.52

T/O Rate:15.26%

Dividend:1.00

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)

Helus Pharma CEO to Spotlight Novel Mental Health Pipeline at Morgan Stanley Healthcare Conference

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Sector Update: Healthcare

MT Newswires Live

Biohaven clinical hold adds level of uncertainty, says H.C. Wainwright

Health Care Roundup: Market Talk

Impact of Biohaven’s partial FDA hold ‘manageable,’ says Raymond James

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)

Community Healthcare management to meet with Piper Sandler

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Prelude Therapeutics receives FDA clearance for PRT13722 IND application

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)

Biohaven faces partial FDA hold on BHV-7000 program

Medtronic (MDT) Receives a Buy from Citi

Edwards Lifesciences (EW) Gets a Buy from Citi

Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/LABU/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":275.2127,"timestamp":1789657870065,"preClose":250.41,"halted":0,"volume":301362,"delay":0,"changeRate":0.09904836068847085,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Trading","change":24.8027,"latestTime":"09-17 11:11:13 EDT","open":265,"high":280.62,"low":263.72,"amount":81817613.1936,"amplitude":0.067489,"askPrice":275.29,"askSize":130,"bidPrice":274.2,"bidSize":40,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.41,"sharesOutstanding":3074486,"nav":250.283,"aum":494179857.69,"dividendRate":0.003639,"bidAskSpread":0.002806,"preHourTrading":{"tag":"盘前","latestPrice":264.96,"preClose":250.41,"latestTime":"09:28 EDT","volume":3396,"amount":879022.60968,"timestamp":1789651729052,"change":14.55,"changeRate":0.058105,"amplitude":0.043329},"postHourTrading":{"tag":"盘后","latestPrice":252.4,"preClose":250.41,"latestTime":"19:58 EDT","volume":3855,"amount":968174.9559,"timestamp":1789603104098,"change":1.99,"changeRate":0.007947,"amplitude":0.007947},"volumeRatio":4.523251,"impliedVol":0.933,"impliedVolPercentile":0.5777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.523251,"shares":1974486,"dividePrice":1.0016,"high":280.62,"amplitude":0.067489,"preClose":250.41,"low":263.72,"week52Low":77.07,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":275.2127,"committee":-0.529412,"eps":0,"divideRate":0.003639,"volume":301362,"delay":0,"ttmEps":0,"open":265,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":266,"twentyDayClose":341.55,"sixtyDayClose":235.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666852516","title":"Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666852516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666852516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:33","pubTimestamp":1789072437,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) has issued an update. On September 8, 2026, Quoin Pharmaceuticals reported that the U.S. Food and Drug Administra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","QNRX","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666272515","title":"XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™","url":"https://stock-news.laohu8.com/highlight/detail?id=2666272515","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666272515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070700,"startTime":"0","endTime":"0","summary":"● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ● CALGARY, Alberta, Sept.  10, 2026 (GLOBE NE","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359975/0/en/xortx-announces-initiation-of-clinical-and-commercial-manufacturing-of-xorlo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","XRTX","EES","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666895518","title":"Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666895518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666895518?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:40","pubTimestamp":1789065605,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eocene (EOCN) and Dyne Therapeutics (DYN). Eocene (EOCN) Maxim Gr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4505","LU0128526141.USD","BK4585","HCSG","DYN","BK4588","BK4137","BK4139","XBI","LU0029874061.USD","LABU","EOCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518845","title":"Helus Pharma CEO to Spotlight Novel Mental Health Pipeline at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518845","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666518845?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:27","pubTimestamp":1789064836,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Helus Pharma ( ($HELP) ). Helus Pharma, operating under the Cybin Inc. banner, is a clinical-stage mental healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/helus-pharma-ceo-to-spotlight-novel-mental-health-pipeline-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/helus-pharma-ceo-to-spotlight-novel-mental-health-pipeline-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","BK4137","BK4581","BK4585","LU0128526141.USD","LABU","XLV","HCSG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559053","title":"Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559053?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:51","pubTimestamp":1789062660,"startTime":"0","endTime":"0","summary":"Ninety percent of the expensive, widely used biologic drugs facing patent expiration by 2034 have no lower-cost alternatives in development, according to a new report by the Association for Accessible","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","IHE","BK4137","LU0128526141.USD","XLV","BK4585","LABU","HCSG","LU0029874061.USD","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666979055","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666979055","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666979055?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:10","pubTimestamp":1789060238,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index shedding 0.2% and the State Street Health Care Select Sector SPDR ETF  down 0.4%.The iShares Biotechnology ETF  dropped 1.3%.In corporate news, Cooper  shares fell past 14% after the company cut its fiscal 2026 guidance. Separately, BofA Securities downgraded Cooper to neutral from buy and lowered its price target to $65 from $80. BofA said Cooper could not sell CooperSurgical at an attractive valuation given competition from the Paragard intrauterine device and the fertility litigation settlement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","BK4581","LABU","LU0128526141.USD","LU1992135399.USD","BK4588","XLV","BK7016","COO","IBB","BK4585","COO.AU","LU1992135472.HKD","HCSG","GB00BDT5M118.USD","LU2211815571.USD","LU2272731600.USD","LU0029874061.USD","XBI","BK4198","LU2272731782.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938597","title":"Biohaven clinical hold adds level of uncertainty, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938597?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:45","pubTimestamp":1789058724,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao keeps a Neutral rating on Biohaven (BHVN) with a $10 price target after the FDA issued a partial clinical hold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-clinical-hold-adds-level-of-uncertainty-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-clinical-hold-adds-level-of-uncertainty-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","SYNB","BK4139","LU1093756325.SGD","LU1093756168.USD","IBB","BHVN","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666927165","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666927165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666927165?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:20","pubTimestamp":1789057200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0208 ET - CSPC Pharmaceutical's coming clinical data presentatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4581","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666756594","title":"Impact of Biohaven’s partial FDA hold ‘manageable,’ says Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2666756594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666756594?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:15","pubTimestamp":1789053317,"startTime":"0","endTime":"0","summary":"Biohaven’s (BHVN) partial FDA hold on new enrollment for BHV-7000 has driven a 15% selloff, but the setback appears manageable given SK Bio’s prior...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/impact-of-biohavens-partial-fda-hold-manageable-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/impact-of-biohavens-partial-fda-hold-manageable-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BGHQF748.EUR","LU0971096721.USD","LU1804176565.USD","LU1093756168.USD","RJF","BK4139","IE00B64PRP62.GBP","LABU","LU2265009873.SGD","BK4588","IE00B3QW5Z07.USD","BK4585","LU1093756325.SGD","BHVN","LU1363072403.SGD","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910045","title":"Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910045?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:40","pubTimestamp":1789051210,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fortrea Holdings Inc. (FTRE) and Immunome (IMNM). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4121","XBI","XLV","LABU","BK4581","BK4137","BK4585","IMNM","HCSG","FTRE","BK4588","LU0029874061.USD","BK4139","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599760","title":"Community Healthcare management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599760","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599760?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:55","pubTimestamp":1789048524,"startTime":"0","endTime":"0","summary":"Meeting to be held on September 17 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/community-healthcare-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/community-healthcare-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4585","KBWY","XBI","BK4588","BK4225","CHCT","LABU","BK4203"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666996625","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666996625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666996625?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","ZYME","LABU","XLV","LU0029874061.USD","BK4007","BK4568","LU0128526141.USD","AXSM","BK4588","BK4563","BK4505","PTH","LU2324357040.USD","OCGN","XBI","BK4139","HCSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666959862","title":"Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2666959862","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666959862?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:30","pubTimestamp":1789039800,"startTime":"0","endTime":"0","summary":"CEO Michael Halstead to participate in a fireside chat on Wednesday, September 16, 2026 at 8:30 a.m. EDT.NEW YORK and TORONTO, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359394/0/en/helus-pharma-to-participate-at-the-morgan-stanley-24th-annual-global-healthcare-conference-in-new-york.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0557290698.USD","LU2023251221.USD","LU2028103732.USD","LU0098860793.USD","HCSG","LU2133065610.SGD","LU1064131342.USD","BK4504","LU0912757837.SGD","LU0528227936.USD","LU0267386448.USD","LU0128526141.USD","LU1988902786.USD","LU0390134368.USD","LU2347655156.SGD","BK4127","LABU","LU0882574139.USD","LU1720051017.SGD","LU1244550494.USD","LU0314104364.USD","LU1548497426.USD","LU0006306889.USD","LU1720051108.HKD","LU0225283273.USD","XLV","LU0106261372.USD","XBI","LU0320765646.SGD","LU1668664300.SGD","BK4588","LU0971096721.USD","LU2271345857.HKD","LU0158827781.USD","LU1732800096.USD","LU1162221912.USD","LU2357305700.SGD","KBWB","IAI","LU1791710400.SGD","LU0158827948.USD","LU0795875169.SGD","LU1989772840.SGD","LU1989772923.USD","LU2111349929.HKD","BK4534","LU0053666078.USD","LU1363072403.SGD","BK4137","LU2089283258.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666856021","title":"Prelude Therapeutics receives FDA clearance for PRT13722 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2666856021","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666856021?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:10","pubTimestamp":1789038614,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics (PRLD) announced that the FDA cleared the company to proceed with a Phase 1 study under its Investigational New Drug Applicati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prelude-therapeutics-receives-fda-clearance-for-prt13722-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prelude-therapeutics-receives-fda-clearance-for-prt13722-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","BK4585","LABU","PRLD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560420","title":"Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560420?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:10","pubTimestamp":1789038608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS). Xeris Pharmace...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-xeris-pharmaceuticals-xers-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-xeris-pharmaceuticals-xers-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","LU0029874061.USD","BK4581","LU0128526141.USD","XERS","XLV","XBI","BK4007","LABU","PHVS","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666356779","title":"Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666356779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666356779?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:50","pubTimestamp":1789037412,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Celldex (CLDX) and Cooper Co (COO) w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunic-imux-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunic-imux-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4581","IMUX","HCSG","BK4585","LU1992135399.USD","LU0128526141.USD","BK4139","LU2211815571.USD","LABU","COO","CLDX","XLV","LU1992135472.HKD","XBI","GB00BDT5M118.USD","BK4588","LU0029874061.USD","LU2272731600.USD","LU2272731782.SGD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567559","title":"Biohaven faces partial FDA hold on BHV-7000 program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567559","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567559?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:32","pubTimestamp":1789036378,"startTime":"0","endTime":"0","summary":"Biohaven Ltd. ( ($BHVN) ) just unveiled an update. In January 2024, Biohaven completed its End-of-Phase 2 meeting with the U.S. FDA for BHV-7000, c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biohaven-faces-partial-fda-hold-on-bhv-7000-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biohaven-faces-partial-fda-hold-on-bhv-7000-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BHV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562198","title":"Medtronic (MDT) Receives a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562198?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:16","pubTimestamp":1789035398,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Buy rating on Medtronic today and set a price target of $110.00. Wuensch covers the Healthcare sector, foc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/medtronic-mdt-receives-a-buy-from-citi-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/medtronic-mdt-receives-a-buy-from-citi-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDT","LU1291159041.SGD","LU0158827781.USD","IE00B3PB1722.GBP","BK4566","BK4585","LU1989764748.USD","LU1057294990.SGD","IE00BFXG1179.USD","LU0314106906.USD","LU1989771016.USD","IE00BDGV0183.EUR","LU0211326755.USD","LU0976567544.SGD","LU2089283258.USD","LU1116320901.HKD","LU1989764664.SGD","LU2028103732.USD","LU2468319806.SGD","IE00B3T34201.USD","LU0265550359.USD","LU1506573853.SGD","IE00BVYPNW00.USD","IE000M9KFDE8.USD","XLV","LU1061106388.HKD","LU2271345857.HKD","LU2112291526.USD","LU0496365809.HKD","LU1571399168.USD","LU0106261372.USD","IE00BQXX3F31.USD","LABU","IE00B42XCP33.USD","IE00BGHQF631.EUR","LU0158827948.USD","LU0432979614.USD","LU0211326839.USD","LU1244550221.USD","BK4533","XBI","LU1116320737.USD","BK4581","LU0006306889.USD","LU0211331839.USD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666968562","title":"Edwards Lifesciences (EW) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666968562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666968562?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:16","pubTimestamp":1789035394,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences today and set a price target of $110.00. Wuensch covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/edwards-lifesciences-ew-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/edwards-lifesciences-ew-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN0W2T93.GBP","LU0058720904.USD","LU0345774631.USD","LU0823416689.USD","SG9999001176.SGD","XBI","BMED","SG9999013999.USD","IE00BFXG0V08.USD","IE00BYQQ9H92.USD","BK4504","AGNG","XLV","BK4588","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4581","BK4082","EW","LU0289739699.SGD","LU0345774391.USD","BK4585","LABU","SGXZ57979304.SGD","BK4567","SG9999001176.USD","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666199562","title":"Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666199562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666199562?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:10","pubTimestamp":1789035029,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Brainsway (BWAY), Cooper Co (COO) and Arcus Biosci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brainsway-bway-cooper-co-coo-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brainsway-bway-cooper-co-coo-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0128526141.USD","LU2211815571.USD","LU1992135472.HKD","LU2272731782.SGD","BWAY","RCUS","XBI","BK4581","LU2272731600.USD","BK4139","HCSG","GB00BDT5M118.USD","BK4588","COO","LU0029874061.USD","LU1992135399.USD","BK4137","LABU","BK4082","BK4585","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":11,"totalSize":402,"code":"91000000","status":"200"}]}}